ARCHIVES

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009

In Brief: Senate Subcommittee Includes $2.7 Billion Increase for NIH in Budget Bill Markup

May 12, 2000

Decision Network Votes 14-11 for Laetrile Testing

September 29, 1978

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

Bevacizumab Prolongs Survival In Patients With Advanced Colorectal Cancer

November 26, 2004

L-PAM, Less Than Radical Surgery Results Holding Up, New Breast Cancer Studies Sought

September 12, 1975